News archive.
Earlier AI news and analysis, kept for reference. Current coverage lives in News & Analysis.
WHO declares Bundibugyo Ebola outbreak international emergency
The UN health agency confirmed 8 lab cases and 80 suspected deaths in DRC's Ituri province, with cross-border spread already documented in Uganda and Kinshasa.
Millet diets boost B12 and vitamin D when paired with supplements
A Delhi trial shows millet-rich meals amplify micronutrient gains beyond supplements alone, but the effect is modest and limited to women.
Chest patch measures stress via five body signals at once
*A bandage-sized sensor worn on the skin detects stress by tracking heart, breath, sweat, blood flow and temperature together—matching traditional polygraph accuracy without wires.*
Robo.ai Subsidiary Neurovia AI to Exhibit at Abu Dhabi Security Conference
*Neurovia AI, a subsidiary of Robo.ai, will present at the 2026 Abu Dhabi National Security and Resilience Exhibition, signaling entry into the government security market.*
Brand Engagement Network posts strongest quarter on record
*A health-focused engagement platform reports record quarterly performance, though full financials and comparative metrics remain undisclosed.*
US surgical system breaks under modest demand shifts
Seasonal hospital surges expose structural fragility. One delayed case cascades into system-wide cancellations affecting thousands of patients yearly.
Pharma firms cut costs on mature drugs through outsourcing
*Strategic outsourcing of legacy drug portfolios can reduce operational burden and unlock value as patents expire.*
FDA clears AstraZeneca blood pressure drug as Pharma revenue race heats up
*Baxdrostat approval marks a major milestone for AstraZeneca's $80B revenue target, but the hypertension market is crowding fast.*
Regeneron's LAG-3 drug fails late-stage skin cancer trial
Fianlimab joins a growing list of LAG-3 inhibitors that have stumbled in clinical development, raising questions about the viability of the target itself.
Gartner compares Heimdal and Sophos for 2026
*Gartner published a comparison of two endpoint security vendors, but the full findings remain behind a paywall.*
Gartner convenes supply chain leaders in Barcelona for first day of 2026 symposium
*Gartner's annual supply chain gathering opens in Barcelona with industry updates; full agenda and speaker insights to follow.*
Gartner expects 40% of government agencies to build deepfake defenses by 2028
Analyst firm forecasts adoption of 'TrustOps' teams in public sector within four years as synthetic media threats accelerate.